NEWS
Neuren biotech rockets on Rett Syndrome trials news
MELBOURNE: Neurological disease biotech Neuren has jumped as much as 109 per cent this morning… read more
Imugene moves forward with cancer vax trial news release
MELBOURNE: Paul Hopper’s $2.7 billion cancer biotech Imugene will move forward with trials for a… read more
18 new senior healthcare executives sought for key roles
MELBOURNE: Eighteen senior healthcare, aged and retirement village executive positions remain open. New positions listed… read more
